For research use only. Not for therapeutic Use.
As a lipid-lowering drug, clofibrate can inhibit the synthesis of cholesterol and triglycerides, increase the excretion of sterols, reduce the content of VLDL in blood, and reduce the content of plasma chemicalbook fibrinogen and the viscosity of platelets. Therefore, it is beneficial to prevent thrombosis and reduce the incidence of myocardial infarction. It is used for hyperlipidemia and atherosclerosis.
| Catalog Number | I004406 |
| CAS Number | 637-07-0 |
| Synonyms | ethyl 2-(4-chlorophenoxy)-2-methylpropanoate |
| Molecular Formula | C12H15ClO3 |
| Purity | ≥95% |
| Target | PPAR |
| Solubility | DMSO 7 mg/mL; Water <1 mg/mL |
| Storage | 2-8°C |
| IUPAC Name | ethyl 2-(4-chlorophenoxy)-2-methylpropanoate |
| InChI | InChI=1S/C12H15ClO3/c1-4-15-11(14)12(2,3)16-10-7-5-9(13)6-8-10/h5-8H,4H2,1-3H3 |
| InChIKey | KNHUKKLJHYUCFP-UHFFFAOYSA-N |
| SMILES | CCOC(=O)C(C)(C)OC1=CC=C(C=C1)Cl |
| Reference | </br>1:Clofibrate as an Adjunct to Phototherapy for Unconjugated Hyperbilirubinemia in Term Neonates. Kumar P, Adhisivam B, Vishnu Bhat B.Indian J Pediatr. 2017 May 17. doi: 10.1007/s12098-017-2360-y. [Epub ahead of print] PMID: 28512725 </br>2:Assessment of Preclinical Liver and Skeletal Muscle Biomarkers Following Clofibrate Administration in Wistar Rats. Maliver P, Festag M, Bennecke M, Christen F, Bánfai B, Lenz B, Winter M.Toxicol Pathol. 2017 Jan 1:192623317707271. doi: 10.1177/0192623317707271. [Epub ahead of print] PMID: 28485676 </br>3:Clofibrate inhibits the umami-savory taste of glutamate. Kochem M, Breslin PA.PLoS One. 2017 Mar 1;12(3):e0172534. doi: 10.1371/journal.pone.0172534. eCollection 2017. PMID: 28248971 Free PMC Article</br>4:Lipid-Lowering Pharmaceutical Clofibrate Inhibits Human Sweet Taste. Kochem M, Breslin PA.Chem Senses. 2017 Jan;42(1):79-83. Epub 2016 Oct 14. PMID: 27742692 </br>5:Clofibrate Demonstrates Efficacy in In Vitro Treatment of Lymphoma and Multiple Myeloma. Schmeel LC, Schmeel FC, Schmidt-Wolf IG.Anticancer Res. 2016 Jul;36(7):3395-400. PMID: 27354598 </br>6:Peroxisome proliferator-activated receptor-α stimulation by clofibrate favors an antioxidant and vasodilator environment in a stressed left ventricle. Ibarra-Lara L, Del Valle-Mondragón L, Soria-Castro E, Torres-Narváez JC, Pérez-Severiano F, Sánchez-Aguilar M, Ramírez-Ortega M, Cervantes-Pérez LG, Pastelín-Hernández GS, Oidor-Chan VH, Zarco-Olvera G, Sánchez-Mendoza A.Pharmacol Rep. 2016 Aug;68(4):692-702. doi: 10.1016/j.pharep.2016.03.002. Epub 2016 Mar 21. PMID: 27110876 </br>7:Biomarker evaluation of skeletal muscle toxicity following clofibrate administration in rats. Bodié K, Buck WR, Pieh J, Liguori MJ, Popp A.Exp Toxicol Pathol. 2016 May;68(5):289-99. doi: 10.1016/j.etp.2016.03.001. Epub 2016 Mar 25. PMID: 27020044 Free Article</br>8:Involvement of Inflammatory Cytokines in Antiarrhythmic Effects of Clofibrate in Ouabain-Induced Arrhythmia in Isolated Rat Atria. Moradi S, Nikoui V, Imran Khan M, Amiri S, Jazaeri F, Bakhtiarian A.Adv Pharmacol Sci. 2016;2016:9128018. doi: 10.1155/2016/9128018. Epub 2016 Feb 10. PMID: 26977143 Free PMC Article</br>9:Effect of clofibrate on fatty acid metabolism in the kidney of puromycin-induced nephrotic rats. Muroya Y, Ito O.Clin Exp Nephrol. 2016 Dec;20(6):862-870. Epub 2016 Mar 7. PMID: 26949064 </br>10:Treatment with PPARα Agonist Clofibrate Inhibits the Transcription and Activation of SREBPs and Reduces Triglyceride and Cholesterol Levels in Liver of Broiler Chickens. Zhang L, Li C, Wang F, Zhou S, Shangguan M, Xue L, Zhang B, Ding F, Hui D, Liang A, He D.PPAR Res. 2015;2015:347245. doi: 10.1155/2015/347245. Epub 2015 Nov 25. PMID: 26693219 Free PMC Article |
